VYTRUS BIOTECH EO -01 (V5P) — Tangible Net Worth Ratio
VYTRUS BIOTECH EO -01 (V5P) has a Tangible Net Worth Ratio of 51.9% as of December 2025. This metric is calculated by deducting intangible assets (€4.96 Million) from net assets (€10.31 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See shareholders equity of VYTRUS BIOTECH EO -01 for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
VYTRUS BIOTECH EO -01 Tangible Net Worth Ratio (2021–2025)
This chart shows how VYTRUS BIOTECH EO -01's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 51.9%, reflecting net assets of €10.31 Million with intangible assets of €4.96 Million EUR. Also explore VYTRUS BIOTECH EO -01 (V5P) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for VYTRUS BIOTECH EO -01 (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for VYTRUS BIOTECH EO -01 from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see VYTRUS BIOTECH EO -01 market capitalisation.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 51.9% | €10.31 Million | €4.96 Million | €14.66 Million | ▲ +7.8 pp |
| 2024 | 44.1% | €7.29 Million | €4.08 Million | €11.13 Million | ▲ +12.7 pp |
| 2023 | 31.4% | €5.29 Million | €3.63 Million | €9.31 Million | ▼ -2.2 pp |
| 2022 | 33.7% | €4.75 Million | €3.15 Million | €8.00 Million | ▲ +0.4 pp |
| 2021 | 33.3% | €4.25 Million | €2.84 Million | €7.18 Million | — |